December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Neil D. Gross: Neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma
Sep 24, 2024, 11:40

Neil D. Gross: Neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma

Neil D. Gross, The Director of Clinical Research in the Department of Head and Neck Surgery at MD Anderson Cancer Center, shared a post on X:

”Latest news on neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma presented last week at the European Society for Medical Oncology 2024, showing durable improved survival at 29.4 months. MD Anderson Cancer Center is excited to launch HN014 NRG Oncology and TROG Cancer Research.”

Neil D. Gross

Source: Neil D. Gross/X